Biosensors Market to be Worth $43.8 Billion by 2030
o
|
|
Download sample Report Here: https://www.meticulousresearch.com/download-sample-report/cp_id=5518
According to this latest publication from
Meticulous Research®, the biosensors market is projected to reach $43.8 billion by
2030, at a CAGR of 8.2% during the forecast period. The growth of this market
is driven by the emergence of nanotechnology-based biosensors in various
end-use industries, the availability of advanced biosensors, and rising
government initiatives. Furthermore, the emerging market in developing
countries and growth potential in the wearable devices market are expected to
create market growth opportunities.
However, the slow rate of commercialization
and high installation and operational costs restrain the growth of this
market. Also, limited adoption in hazardous sectors and the unexplored
potential of biosensors pose major challenges for the players in this market.
The biosensors market is segmented by
product, type, application, and industry. The study also evaluates industry
competitors and analyzes the market at the region/country level.
Based on product, the biosensors market
is segmented into wearable biosensors and non-wearable biosensors. The
wearable biosensors segment is further segmented into embedded devices and
non-embedded devices. In 2023, the wearable biosensors segment is expected to
account for a larger share of the global biosensors market. The large market
share of this segment is mainly attributed to wearable biosensors’ potential
to enhance medical diagnostics and continuous health monitoring capabilities.
Additionally, wearable biosensor applications aim to change centralized
hospital-based care systems to home-based personal medicine and reduce
healthcare costs and the duration required for diagnosis.
Based on type, the biosensors
market is segmented into electrochemical biosensors, optical biosensors,
piezoelectric biosensors, thermal biosensors, and other biosensor types. In
2023, the electrochemical biosensors segment is expected to account for the
largest share of the global biosensors market. The large market share of this
segment is mainly attributed to its advantages such as low detection limits,
wide linear response range, excellent stability, and repeatability.
Additionally, electrochemical biosensors are highly used in non-medical
applications, such as environmental monitoring and quality control of food
& beverages.
Based on application, the biosensors
market is segmented into medical, food toxicity, agriculture, wastewater
treatment, and other applications. The medical segment is further segmented
into cholesterol monitoring, blood glucose testing, pregnancy testing,
infectious testing, and other medical applications. In 2023, the medical
segment is expected to account for the largest share of the global biosensors
market. The large market share of this segment is attributed to the wider
usage of biosensors in the medical field for cholesterol testing, blood
glucose monitoring, drug discovery, pregnancy testing, infectious disorders,
and other medical testing.
Speak to analyst: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5518
Based on industry, the biosensors
market is segmented into healthcare, food & beverages, forensic and
biodefense, environmental monitoring, and other industries. In 2023, the
healthcare segment is expected to account for the largest share of the global
biosensors market. The large market share of this segment is attributed to the
technological advancements that create innovative products and growing
investments, funds, and grants.
Based on geography, the biosensors
market is segmented into North America, Europe, Asia-Pacific, Latin America,
and the Middle East & Africa. In 2023, North America is expected to
account for the largest share of the biosensors market, followed by
Asia-Pacific, Europe, Latin America, and the Middle East & Africa. The
rapid growth of this market is attributed to increasing health awareness, the
rising aging population, growing chronic and lifestyle illnesses, and
technological progress for several uses at home and proper insurance coverage.
Key Players:
The key players operating in the biosensors
market are F. Hoffmann-La Roche Ltd (Switzerland), Abbott Laboratories (U.S.),
Thermo Fisher Scientific Inc. (U.S.), Danaher Corporation (U.S.), DuPont de
Nemours, Inc. (U.S.), Siemens Healthineers AG (Germany), Ercon, Inc. (U.S.),
Innovative Biosensors Inc. (U.S.), Ascensia Diabetes Care Holdings AG
(Switzerland), Bio-Rad Laboratories, Inc (U.S.), Biosensors International
Group, Ltd. (Singapore), Dexcom, Inc. (U.S.), LifeScan Inc. (U.S.), Masimo
Corporation (U.S.), Nova Biomedical (U.S.), Pinnacle Technologies Inc. (U.S.),
QTL Biosystems (U.S.), and TE Connectivity Corporation (Switzerland).
Quick Buy: https://www.meticulousresearch.com/Checkout/31583757
Key questions answered in
the report-
· Which are
the high-growth market segments based on product, type, application, industry,
and geography?
· What was
the historical market for biosensors market?
· What are
the market forecasts and estimates for the period 2023–2030?
· What are
the major drivers, restraints, opportunities, challenges, and trends in the
biosensors market?
· Who are
the major players, and what shares do they hold in the biosensors market?
· How is the
competitive landscape in the biosensors market?
· What are
the recent developments in the biosensors market?
· What
strategies are adopted by the major players in the biosensors market?
· What are
the key geographic trends, and which are the high-growth countries?
· Who are
the local emerging players in the global biosensors market, and how do they
compete with the other players?
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous- research
Comments
Post a Comment